drugset

drugset / Trial / NCT00043459

Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

NCT00043459 ↗

Phase 2 Terminated 35 enrolled Tularik

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine whether T900607-sodium is effective and safe in treating non-Hodgkin's lymphoma.

Timeline

Start: 2002-07
Primary completion: —
Completion: 2003-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	T900607	Small molecule	—	Intravenous

Indications